Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    curcumin
Show Display Options
Rank Status Study
1 Completed Effects of Curcumin on Vascular Reactivity
Condition: Healthy Volunteers (Middle-aged Smokers)
Intervention: Drug: Curcumin
2 Unknown  Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
Conditions: Type 2 Diabetes;   Pre-diabetes;   Insulin Resistance;   Cardiovascular Risk
Intervention: Drug: Curcumin
3 Completed Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma
Condition: Atopic Asthma
Interventions: Dietary Supplement: CURCUMIN;   Other: no intervention other than stopping study
4 Active, not recruiting 18-Month Study of Curcumin
Conditions: Age-associated Cognitive Impairment;   Mild Cognitive Impairment (MCI)
Interventions: Drug: Curcumin;   Other: Placebo
5 Completed
Has Results
Oral Curcumin for Radiation Dermatitis
Condition: Radiation-induced Dermatitis
Interventions: Drug: Curcumin;   Drug: Placebo
6 Recruiting Topical Curcumin for Precancer Cervical Lesions
Condition: Neoplasms
Interventions: Drug: Curcumin;   Drug: Placebo
7 Completed Curcumin Biomarkers
Condition: Colorectal Cancer
Intervention: Drug: Curcumin C3 tablet
8 Active, not recruiting Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)
Condition: Oral Submucous Fibrosis
Intervention: Drug: Curcumin Arm
9 Completed Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
Condition: Uterine Cervical Dysplasia
Interventions: Drug: Curcumin;   Drug: curcumin
10 Recruiting A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Condition: Lung Cancer
Interventions: Dietary Supplement: CurcuVIVA™;   Drug: Tyrosine Kinase Inhibitor gefitinib (Iressa);   Drug: Tyrosine Kinase Inhibitor erlotinib (Tarceva)
11 Active, not recruiting Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue
Condition: Colon Cancer
Interventions: Dietary Supplement: curcumin;   Dietary Supplement: Curcumin conjugated with plant exosomes;   Other: No intervention
12 Completed The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects
Condition: Healthy
Intervention: Dietary Supplement: curcumin
13 Unknown  Curcumin for Type 2 Diabetic Patients
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Abnormalities
Intervention: Drug: curcumin
14 Recruiting Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Calcumin (Curcumin);   Other: Risk Factor Questionnaire;   Other: Blood samples;   Other: Biopsies (Sigmoidoscopy);   Other: Biopsies (Upper endoscopy)
15 Recruiting Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease
Condition: Crohn's Disease
Intervention: Drug: Curcumin
16 Recruiting A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Dietary Supplement: curcumin 1800mg;   Dietary Supplement: Placebo
17 Unknown  Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
Conditions: Schizophrenia;   Cognition;   Psychosis
Intervention: Drug: Curcumin
18 Recruiting Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Condition: Chronic Schizophrenia
Interventions: Drug: Curcumin;   Drug: placebo
19 Recruiting Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease
Condition: Mild Cognitive Impairment
Interventions: Drug: Curcumin;   Behavioral: aerobic yoga;   Behavioral: non aerobic yoga;   Dietary Supplement: Placebo
20 Completed Evaluation of Liposomal Curcumin in Healthy Volunteers
Condition: Drug Safety
Interventions: Drug: Liposomal Curcumin;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.